Abstract:Background and objectives: Inherited thrombocytopenias are a heterogeneous group of rare diseases characterized by a reduced number of blood platelets. Some of these diseases are exclusive to megakaryocytes and platelets, while in others the pathology extends to other cell types. Although the defective genes, coding for membrane glyoproteins, cytoskeleton components and intracellular signaling pathways, as well as transcription factors, have been identified in most cases, the pathophysiology of these disorders is often unknown. This review describes recent contributions to clinical and diagnostic aspects, biology and treatments of familial thrombocytopenias. Evidence and information sources: The information presented here derives from literature and the experience of the authors. The most relevant studies are critically analyzed and discussed. State of art: The clinical and laboratory features of most of the inherited thrombocytopenias have been reviewed. The different forms have been classified into 3 groups depending on platelet volume. Although this criterion is not completely satisfactory, it is one of the most useful in diagnostic algorithms. We report on recent advances in Wiskott-Aldrich and Bernard-Soulier syndromes, as well as in MYH9-related diseases, a new nosological entity that groups old distinct forms known as May-Hegglin anomaly, Sebastian, Fetchner, and Epstein syndromes. Other, less frequent forms are also discussed, including non-syndromic forms of mild thrombocytopenia that are genetically heterogeneous. Perspectives: In the past, inherited thrombocytopenias were considered exceedingly rare and the number of well-defined forms was very small. In the last few years, the widespread diffusion of electronic cell counters has allowed these conditions to be detected more frequently and several new entities have been identified through the co-ordinated efforts of physicians, biologists and geneticists. The pathogenesis of many new and old forms is being unraveled, thus providing insights on the molecular basis of platelet production and function. This knowledge will be a valuable resource for clinicians in the diagnostic approaches to such disorders.

Biological, clinical features and modelling of heterozygous variants of glycoprotein Ib platelet subunit alpha (GP1BA) and glycoprotein Ib platelet subunit beta (GP1BB) genes responsible for constitutional thrombocytopenia

Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

A novel frameshift GP1BB mutation causes autosomal dominant macrothrombocytopenia with decreased vWF receptor expression but normal platelet aggregation

A novel germline mutation in GP1BA gene N-terminal domain in monoallelic Bernard-Soulier syndrome

A mutation of the human EPHB2 gene leads to a major platelet functional defect

Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE

Inherited traits affecting platelet function

Mechanisms of thrombocytopenia in platelet-type von Willebrand disease

Hereditary thrombocytopenia with platelet sialic acid deficiency and mutations in the GNE genes

Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy

Bernard–Soulier Syndrome Caused by Two Novel Heterozygous GP1BA Gene Mutations: a Case Report and Literature Review

Inherited thrombocytopenias: from genes to therapy

Clinical-biological diagnosis for hereditary thrombocytopenias

Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.

Advances in our understanding of the molecular basis of disorders of platelet function

Identification of a pathogenic <i>TUBB1</i> variant in a Chinese family with congenital macrothrombocytopenia through whole genome sequencing

A Novel GATA1 Variant P.g229d Causing the Defect of Procoagulant Platelet Formation

[A preliminary study of an inherited macrothrombocytopenia disorder with abnormal large granules]

Advances in understanding the pathogenesis of hereditary macrothrombocytopenia

Platelet-Type von Willebrand Disease: New Insights into the Molecular Pathophysiology of a Unique Platelet Defect

Recent advances in inherited platelet disorders